ABM Respiratory Care Raises $10.3M in Series A Funding Round: Company to Advance Commercialization in the US

October 27, 2020

ABM Respiratory Care, a medical device company focused on developing novel integrated airway clearance and ventilation solutions, announced today the raise of US$10.3M in its series A funding round led by Advanced MedTech Holdings, a global medical technology leader, and SEEDS Capital, the investment arm of Enterprise Singapore. The funding will help ABM advance their US commercialization plans.

ABM Respiratory Care also announced the appointment of Peter H. Soderberg as Chairman of the company’s Board of Directors. Mr. Soderberg currently serves as the Chairman of the Board of Directors for Tactile Medical, a publicly-traded medical device company. Mr. Soderberg recently concluded 18 years of service on the board of directors of Integer Holdings Corp. (formerly Greatbatch, Inc.), a medical technology company. Mr. Soderberg previously served on the boards of Constellation Brands, Inc. and the Advanced Medical Technology Association.

In addition, Mr. Soderberg is currently the Managing Partner of Worthy Venture Resources, LLC, a company focused on growing commercial-stage companies to a global market presence. Before his semi-retirement in 2010, he served as President and Chief Executive Officer of Hillenbrand Industries and Hill-Rom, and, before that, of Welch Allyn. He has previously held executive positions at Johnson and Johnson in a variety of operations, marketing, and management roles, including President of Johnson & Johnson Health Management.

“We are delighted to have Mr. Soderberg join ABM as chairman of our board of directors,” Vinay Joshi, CEO of ABM Respiratory Care, commented, “His appointment comes at a great time for the company since we recently completed our Series A funding of US$10.3 million, secured a significant order for our Alpha ventilator, and received 510(k) clearance by the US FDA for our BiWaze™ Airway Clearance System earlier this year. Mr. Soderberg is a seasoned medical industry leader who has decades of experience leading successful medical device companies. ABM Respiratory Care will leverage his experience as we execute our corporate strategy.”

“I welcome the opportunity to join ABM Respiratory Care as the Chairman of the Board of Directors,” Mr. Soderberg said. “I’m excited to work with ABM to advance the standard of care in treating chronic and acute respiratory diseases and conditions with their innovative solutions, particularly as they now seek to rapidly establish their U.S. presence.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

“We are excited to begin our journey as a public company with this additional investment. We believe Tevogen’s patient-centric approach, which merges a focus on affordability with advanced science, is a blueprint for sustainable success in the current era of healthcare. I am pleased that investors now have the opportunity to participate in Tevogen’s mission to become the very first life science company offering commercially attractive and affordable personalized T cell therapies for large patient populations in virology, oncology, and neurology, said the CEO of Tevogen Bio.
MB2 Dental notes the financing will be used to fund upcoming acquisitions and future growth for the company, following a record year of growth in 2023 with 150 new partnerships.
Procyrion notes the funding will support the DRAIN-HF pivotal IDE trial evaluating the company's Aortix pump, internal R&D programs to improve manufacturability, and commercialization preparation.
PhotoniCare, in January of this year, announced that the U.S. Food and Drug Administration had granted clearance for its TOMi™ Scope for non-invasive imaging of the middle ear.
Vicarious Surgical added Philip Liang and Ric Fulop to their Board of Directors. 

By using this website you agree to accept Medical Device News Magazine Privacy Policy